02/04/2024
THC legal update: ‘The proposed update to Schedule 6 of the Medicines Act intends to exclude certain cannabis products containing Tetrahydrocannabinol (THC), the psychoactive compound in cannabis, from the operation of the Schedules to the Medicines Act and will, inter alia, permit the manufacturing of cannabis consumer items and products, with no limitation on the percentage of THC content, provided that the items and products have no pharmacological action or medicinal purpose. This will also allow adults to cultivate and possess cannabis in private for personal consumption, with no limitation on the percentage of THC content.’ **ptoday -
In terms of the Medicines Act, and on the recommendation of the South African Health Products Regulatory Authority, the Minister of Health has invited interested persons to submit substantiated comments or representations on the proposed update of Schedule 6 to the Act...